What Is AstraZeneca (LSE:AZN) Signaling With Its Latest Late Stage Trial Results?
AstraZeneca (LSE:AZN) reported positive high level results across several late stage oncology and immunology trials, including TEZSPIRE in…
3 UK Stocks Estimated To Be Trading Below Intrinsic Value By At Least 12.8%
The UK stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines…
AstraZeneca Stock Remains 14% Lower Despite Tezspire Phase 3 Success
This article first appeared on GuruFocus. AstraZeneca (NYSE:AZN), the global pharmaceutical and oncology company, traded at $164.75 Thursday…
AstraZeneca Stock Remains 14% Lower Despite Tezspire Phase 3 Suc
AstraZeneca AZN, the global pharmaceutical and oncology company, traded at $164.75 Thursday as positive Tezspire data failed to…
AstraZeneca shares slump after $400bn BMS merger rumours
Shares in AstraZeneca dropped by nearly 3% at market open after a report that the drugmaker is in…
AstraZeneca growth spurs regional workforce push in Central Virginia
ALBEMARLE COUNTY, Va. (WVIR) – AstraZeneca’s planned move into Albemarle County is expected to bring billions of dollars…
New data could widen use of AstraZeneca, Amgen immune disease drug
AstraZeneca and Amgen’s Tezspire met the main goals of a late-stage trial in another inflammatory disease, a win…
UK Shares Fall as Global Tensions Mount; AstraZeneca Drops
MT Newswires -Shutterstock British equities traded in the red on Thursday, with the FTSE 100 down 0.75% at…
AstraZeneca stock slips as Tezspire trial success fails to lift shares
AstraZeneca (US6549022043) stock traded modestly lower on August 27, 2026, in London despite positive late-stage trial results for…
Merck and Moderna cancer vaccine, Ionis, AstraZeneca: Readout
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
AstraZeneca prices €2.55bn euro bond sale across four tranches
AstraZeneca prices €2.55bn euro bond sale across four tranches Proactive uses images sourced from Shutterstock AstraZeneca PLC (LSE:AZN,…
AstraZeneca asthma drug succeeds in oesophagus trial
AstraZeneca has announced the success of its asthma drug in a late-stage oesophagus disease trial. The British Swedish pharmaceutical company said on Thursday that…